Detalles de la búsqueda
1.
Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS).
Br J Dermatol
; 189(5): 561-568, 2023 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37479503
2.
Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study.
Rheumatology (Oxford)
; 61(4): 1589-1599, 2022 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34244706
3.
Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database.
Rheumatology (Oxford)
; 60(3): 1243-1251, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32911531
4.
Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
Dermatology
; 237(5): 748-758, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33503635
5.
Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France.
Ann Rheum Dis
; 82(5): e117, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859610
6.
Risk of serious infection associated with different classes of targeted therapies used in psoriatic arthritis: a nationwide cohort study from the French Health Insurance Database (SNDS).
RMD Open
; 10(1)2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485454
7.
Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS).
RMD Open
; 9(4)2023 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114199
8.
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database.
JAMA Dermatol
; 158(5): 513-522, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35319735
9.
Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System.
Arthritis Rheumatol
; 74(2): 244-252, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34279061
10.
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis.
JAMA Dermatol
; 157(9): 1056-1065, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34287624
11.
Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Hypertension
; 77(3): 833-842, 2021 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33423528
12.
Association Between Adult Acne and Dietary Behaviors: Findings From the NutriNet-Santé Prospective Cohort Study.
JAMA Dermatol
; 156(8): 854-862, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32520303
13.
First-Line Persistence of Biologics in Psoriasis from a Cohort Based on French Medico-Administrative Data.
J Invest Dermatol
; 143(9): 1819-1822.e3, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36997111
14.
Reply.
Arthritis Rheumatol
; 74(3): 547-548, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463052
Resultados
1 -
14
de 14
1
Próxima >
>>